Archit Organosys Ltd

Archit Organosys Annual Report

Archit Organosys Limited issued a corrigendum to its FY 2025-26 Annual Report, withdrawing Agenda Items 8, 9, and 10 from the upcoming AGM notice.

Archit Organosys Annual General Meeting

Archit Organosys has withdrawn three agenda items from the upcoming AGM, including an authorised capital increase, an acquisition, and a proposed preferential issue for restructuring.

Archit Organosys Annual General Meeting

Archit Organosys Limited announced its 33rd Annual General Meeting to be held on 30th September 2026. The board recommended a dividend of Re. 1 per share.

Archit Organosys Annual Report

Archit Organosys Ltd has filed its Annual Report for the financial year 2025-26. The submission includes audited financial statements and director's reports for the period.

Archit Organosys Dividend

Archit Organosys has fixed September 23, 2026, as the record date to determine shareholder eligibility for the final dividend recommended for FY 2025-26.

Archit Organosys Capital Structure Change

Archit Organosys will issue 3.72 crore shares via preferential allotment at ₹65/share, totaling ₹242.11 Crore, to acquire a stake in Archit Life Science Limited.

Value

₹242.1 Cr

Archit Organosys Board Meeting Date

Archit Organosys Ltd announced a board meeting on September 3, 2026, to evaluate proposals for raising funds through the issuance of equity shares or other securities.

Archit Organosys Q1 FY27 Results: Net Profit ₹1.4 Cr, Down 30.0% YoY

Archit Organosys Ltd reported revenue from operations of ₹37.1 Cr (+11.7% YoY) and net profit of ₹1.4 Cr (-30.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.4 Cr · -30.0% YoY

Archit Organosys Board Meeting Date

Archit Organosys has scheduled a Board Meeting on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Archit Organosys Q4 FY26 Results: Net Profit ₹2 Cr, Up 0.0% YoY

Archit Organosys Ltd reported revenue from operations of ₹36.5 Cr (-15.5% YoY) and net profit of ₹2 Cr (+0.0% YoY) for Q4 FY26.

Key figure

Net profit ₹2 Cr · +0.0% YoY

Archit Organosys Financial Results

Archit Organosys approved audited financial results for fiscal year 2026, reporting a profit of ₹8.05 Crore. The board also recommended a ₹1 per share final dividend for investors.

Archit Organosys Board Meeting Date

Archit Organosys scheduled a board meeting on May 16, 2026, to approve audited annual results and dividend. The trading window remains closed for designated persons.

Archit Organosys Board Meeting Date

Archit Organosys Limited scheduled a board meeting for May 16, 2026, to approve annual financial results. The trading window remains closed until 48 hours post-announcement.

Archit Organosys Price Movement Clarification

Archit Organosys Ltd clarified to BSE that recent share price movements are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or impending corporate actions. It remains in compliance with SEBI LODR regulations regarding all necessary disclosures.